Advert: 728x90_HH_jan08
line
Industry News  |  JobSearch  |  Magazine  |  Competitions & Events  |  Clubs  |  Forums  |  Directory  
Where am I? > Home > Forums
Disclaimer
Discussion contents reflect the views of individual participants only. PharmaTimes bear no responsibility for accuracy of participant comments and will bear no legal liability for discussion results.
None of the messages, chats or postings is screened for content. However, PharmaTimes reserves the right to delete any material.

Discussions

Forums Last Post Threads Posts
No unread posts Articles
Forums for articles posted on PharmaTimes.com
Luxembourg top,...
07-04-2008 10:44 AM
 
1,778 1,781

Who is Online

There are 21 guest(s) online. There are 0 member(s) online.

Forum Statistics

36 users have contributed to 1,807 threads and 1,811 posts.

In the past 24 hours, we have 7 new thread(s), 7 new post(s), and 0 new user(s).

In the past 3 days, the most popular thread for everyone has been "Novartis and GSK to appeal Alabama price-fixing damages". The post with the most views is "Bayer gets its hands on Maxygen’s haemophilia assets". The most replies were made to "Novartis and GSK to appeal Alabama price-fixing damages".

Please welcome our newest member ilsemaria.
Login Subscribe Advertise
Register Recommend Bookmark
 
Search
  Go
  Go
 
Find
 
 
 
 
WEBSITE AUDIT BY MAGAZINE AUDIT BY
BPA Logog ABC Logo
line